#EULAR2022 POS0235: Filgotinib Safety in RA for Median 2.2 years: ▶️No new safety concerns from 2020 report with shorter f/u ▶️Adverse events stable, or decreased, from early studies @Rheumnow https://t.co/DO15Tqim4n